Submitted by Anonymous (not verified) on 17 October 2025 - 9:25
Opinion/decision on a Paediatric investigation plan (PIP): Ghryvelin (previously Macimorelin Aeterna Zentaris), Macimorelin, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrine disorders, PIP number: P/0331/2024
Source: